bioRxivMicrobiology
The cyclic nitroxide antioxidant 4-methoxy-TEMPO decreases mycobacterial burden in vivo through host and bacterial targets
H. D. Black, W. Xu, E. Hortle, S. I. Robertson, W. J. Britton, A. Kaur, E. J. New, P. K. Witting, B. Chami, S. Oehlers
Abstract
Tuberculosis is a chronic inflammatory disease caused by persistent infection with Mycobacterium tuberculosis. The rise of antibiotic resistant strains necessitates the design of novel treatments. Recent evidence shows that not only is M. tuberculosis highly resistant to oxidative killing, it also co-opts host oxidant production to induce phagocyte death facilitating bacterial dissemination. We have targeted this redox environment with the cyclic nitroxide derivative 4-methoxy-TEMPO (MetT) in the zebrafish-M. marinum infection model. MetT inhibited the production of mitochondrial ROS and decreased infection-induced cell death to aid containment of infection. We identify a second mechanism of action whereby stress conditions, including hypoxia, found in the infection microenvironment appear to sensitise M. marinum to killing by MetT both in vitro and in vivo. Together, our study demonstrates MetT inhibited the growth and dissemination of M. marinum through host and bacterial targets.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Moxifloxacin-mediated killing of Mycobacterium tuberculosis involves respiratory downshift, reductive stress, and ROS accumulation
- Effects of Exogenous Nitric Oxide Gas on Mycobacterium tuberculosis in vitro and in mice
Xiuju Jiang, Carl Nathan·bioRxiv·Aug 19, 2026
- Uncovering the Roles of Mycobacterium tuberculosis melH in Redox and Bioenergetic Homeostasis: Implications for Antitubercular Therapy
Y.-c. Chen, X. Yang, … N. S. Sampson·bioRxiv·Oct 2, 2023
- Hypothetical gene Rv0495c regulates redox homeostasis in Mycobacterium tuberculosis
R. Pal, S. Talwar, … A. K. Pandey·bioRxiv·Aug 22, 2023
- An oxadiazole-based compound potentiates anti- tuberculosis treatment by increasing host resistance via zinc poisoning
A. Maure, E. Lawaree, … L. Tailleux·bioRxiv·Jul 21, 2023
- Bioenergetic reprogramming of macrophages reduces drug tolerance in Mycobacterium tuberculosis
Vikas Yadav, Sarthak Sahoo, … Amit Singh·bioRxiv·Jan 24, 2025